{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:35:09Z","timestamp":1791999309369,"version":"4.4.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00331","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T04:39:03Z","timestamp":1594269543000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":127,"title":["Selective Thyroid Hormone Receptor-Beta (TR\u03b2) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders"],"prefix":"10.3389","volume":"7","author":[{"given":"Federica","family":"Saponaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sestito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Runfola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rapposelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Chiellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1210\/edrv.22.4.0435","article-title":"Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability","volume":"22","author":"Hennemann","year":"2001","journal-title":"Endocr Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10741-016-9553-8","article-title":"Tissue thyroid hormones and thyronamines","volume":"21","author":"Accorroni","year":"2016","journal-title":"Heart Failure Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","article-title":"The effect of thyroid hormone on skeletal integrity","volume":"130","author":"Greenspan","year":"1999","journal-title":"Ann Intern Med."},{"key":"B5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-7902-8_9","article-title":"Thyroid hormones and derivatives: endogenous thyroid hormones and their targets","volume-title":"Thyroid Hormone Nuclear Receptor. Methods in Molecular Biology","author":"K\u00f6hrle","year":"2018"},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12020-019-02018-4","article-title":"Novel thyroid hormones","volume":"66","author":"Zucchi","year":"2019","journal-title":"Endocrine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fendo.2019.00088","article-title":"Assay of endogenous 3, 5-diiodo-L-thyronine (3, 5-T2) and 3, 3'-diiodo-L-thyronine (3, 3'-T2) in human serum: a feasibility study","volume":"10","author":"Lorenzini","year":"2019","journal-title":"Front Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3727\/105221617X14968563796227","article-title":"GC-1: a thyromimetic with multiple therapeutic applications in liver disease","volume":"17","author":"Columbano","year":"2017","journal-title":"Gene Exp J Liver Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1567201813666151123124340","article-title":"3, 5-Diiodo-L-thyronine: a possible pharmacological agent?","volume":"13","author":"Coppola","year":"2016","journal-title":"Curr Drug Deliv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1527-3466.2005.tb00161.x","article-title":"Development of the thyroid hormone receptor \u03b2-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects","volume":"23","author":"Grover","year":"2005","journal-title":"Cardiovasc Drug Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid."},{"key":"B12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.yfrne.2007.09.003","article-title":"Mechanisms of nongenomic actions of thyroid hormone","volume":"29","author":"Davis","year":"2008","journal-title":"Front Neuroendocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrendo.2015.205","article-title":"Nongenomic actions of thyroid hormone","volume":"12","author":"Davis","year":"2016","journal-title":"Nat Rev Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1210\/en.2017-00250","article-title":"Thyroid hormone signaling pathways: time for a more precise nomenclature","volume":"158","author":"Flamant","year":"2017","journal-title":"Endocrinology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/324641a0","article-title":"The c-erb-A gene encodes a thyroid hormone receptor","volume":"324","author":"Weinberger","year":"1986","journal-title":"Nature."},{"key":"B16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/324635a0","article-title":"The c-erb-A protein is a high-affinity receptor for thyroid hormone","volume":"324","author":"Sap","year":"1986","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1124\/pr.58.4.3","article-title":"International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors","volume":"58","author":"Flamant","year":"2006","journal-title":"Pharmacol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","article-title":"Combinatorial control of gene expression by nuclear receptors and coregulators","volume":"108","author":"McKenna","year":"2002","journal-title":"Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1010052101214","article-title":"Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors","volume":"1","author":"Cheng","year":"2000","journal-title":"Rev Endocr Metab Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1210\/me.2011-1290","article-title":"Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding","volume":"26","author":"Chiamolera","year":"2012","journal-title":"Mol Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.yjmcc.2008.02.076","article-title":"Thyroid hormone receptor alpha 1: a switch to cardiac cell \u201cmetamorphosis\u201d","volume":"59","author":"Pantos","year":"2008","journal-title":"J Physiol Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.2007.0288","article-title":"Effects of thyroid hormone analogs on lipid metabolism and thermogenesis","volume":"18","author":"Ribeiro","year":"2008","journal-title":"Thyroid."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s40265-017-0791-4","article-title":"Potential role of thyroid receptor \u03b2 agonists in the treatment of hyperlipidemia","volume":"77","author":"Jakobsson","year":"2017","journal-title":"Drugs."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/thy.2019.0007","article-title":"A liver-specific thyromimetic, VK2809, decreases hepatosteatosis in glycogen storage disease type Ia","volume":"29","author":"Zhou","year":"2019","journal-title":"Thyroid."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0071","article-title":"Thyroid hormone analogues: an update","author":"Zucchi","year":"2020","journal-title":"Thyroid."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-02025-5","article-title":"Thyroid hormone metabolites and analogues","volume":"66","author":"Senese","year":"2019","journal-title":"Endocrine."},{"key":"B27","doi-asserted-by":"publisher","first-page":"16158","DOI":"10.3390\/ijms160716158","article-title":"Thyroid hormone mediated modulation of energy expenditure","volume":"16","author":"Vaitkus","year":"2015","journal-title":"Int J Mol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2013.06.006","article-title":"Thyroid hormones and mitochondria: with a brief look at derivatives and analogues","volume":"379","author":"Cioffi","year":"2013","journal-title":"Mol Cell Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1210\/me.2002-0009","article-title":"Requirement for thyroid hormone receptor \u03b2 in T3 regulation of cholesterol metabolism in mice","volume":"16","author":"Gullberg","year":"2002","journal-title":"Mol Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"601361","DOI":"10.1155\/2013\/601361","article-title":"Molecular functions of thyroid hormones and their clinical significance in liver-related diseases","volume":"2013","author":"Chi","year":"2013","journal-title":"BioMed Res Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.22793","article-title":"Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States","volume":"49","author":"Hassan","year":"2009","journal-title":"Hepatology."},{"key":"B33","first-page":"603","article-title":"Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas","volume":"60","author":"Ledda-Columbano","year":"2000","journal-title":"Cancer Res."},{"key":"B34","volume-title":"Thyroid Hormone Actions: To Be ta or Not to Be ta","author":"Mariash","year":"2010"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1210\/mend.14.11.0548","article-title":"Thyroid hormone receptor \u03b2-deficient mice show complete loss of the normal cholesterol 7\u03b1-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol","volume":"14","author":"Gullberg","year":"2000","journal-title":"Mol Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"R640","DOI":"10.1152\/ajpregu.1998.275.2.R640","article-title":"Evidence that decreased heart rate in thyroid hormone receptor-\u03b11-deficient mice is an intrinsic defect","volume":"275","author":"Johansson","year":"1998","journal-title":"Am J Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1210\/endo.142.2.7935","article-title":"Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor \u03b1 or \u03b2","volume":"142","author":"Gloss","year":"2001","journal-title":"Endocrinology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/B978-0-12-801238-3.99453-4","article-title":"Subclinical hyperthyroidism","volume":"4","author":"Biondi","year":"2018","journal-title":"New Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000492129","article-title":"Effect of thyroid hormones on neurons and neurodevelopment","volume":"90","author":"Prezioso","year":"2018","journal-title":"Hormone Res Paediatr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1523\/JNEUROSCI.12-06-02288.1992","article-title":"Spatial and temporal expression of alpha-and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system","volume":"12","author":"Bradley","year":"1992","journal-title":"J Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.5163-07.2008","article-title":"Locomotor deficiencies and aberrant development of subtype-specific GABAergic interneurons caused by an unliganded thyroid hormone receptor \u03b11","volume":"28","author":"Wallis","year":"2008","journal-title":"J Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/bs.ctdb.2017.01.001","article-title":"Genetic investigation of thyroid hormone receptor function in the developing and adult brain","volume":"125","author":"Flamant","year":"2017","journal-title":"Curr Top Dev Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mce.2017.01.041","article-title":"Traversing barriers\u2013how thyroid hormones pass placental, blood-brain and blood-cerebrospinal fluid barriers","volume":"458","author":"Landers","year":"2017","journal-title":"Mol Cell Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1210\/en.2011-1633","article-title":"Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain","volume":"153","author":"Mayerl","year":"2012","journal-title":"Endocrinology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/glia.21116","article-title":"Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells","volume":"59","author":"Braun","year":"2011","journal-title":"Glia."},{"key":"B46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/mcne.1999.0790","article-title":"From neural stem cells to myelinating oligodendrocytes","volume":"14","author":"Rogister","year":"1999","journal-title":"Mol Cell Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"16363","DOI":"10.1073\/pnas.0407262101","article-title":"Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease","volume":"101","author":"Fernandez","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"101443","DOI":"10.1016\/j.scr.2019.101443","article-title":"The role of nuclear receptors in the differentiation of oligodendrocyte precursor cells derived from fetal and adult neural stem cells","volume":"37","author":"Baldassarro","year":"2019","journal-title":"Stem Cell Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1471-4159.2010.06974.x","article-title":"A single prenatal exposure to the endocrine disruptor 2,3,7,8-tetrachlorodibenzo-p-dioxin alters developmental myelination and remyelination potential in the rat brain","volume":"115","author":"Fern\u00e1ndez","year":"2010","journal-title":"J Neurochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0166-2236(00)01691-X","article-title":"The oligodendrocyte precursor cell in health and disease","volume":"24","author":"Levine","year":"2001","journal-title":"Trends Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1210\/me.2011-1316","article-title":"A bimodal influence of thyroid hormone on cerebellum oligodendrocyte differentiation","volume":"26","author":"Picou","year":"2012","journal-title":"Mol Endocrinol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.expneurol.2014.12.021","article-title":"Transferrin and thyroid hormone converge in the control of myelinogenesis","volume":"265","author":"Marziali","year":"2015","journal-title":"Exp Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1006\/dbio.2001.0293","article-title":"Role of thyroid hormone receptors in timing oligodendrocyte differentiation","volume":"235","author":"Billon","year":"2001","journal-title":"Dev Biol."},{"key":"B54","doi-asserted-by":"crossref","first-page":"24699","DOI":"10.1016\/S0021-9258(17)31447-3","article-title":"Transcriptional repression of Xenopus TR beta gene is mediated by a thyroid hormone response element located near the start site","volume":"269","author":"Ranjan","year":"1994","journal-title":"J Biol Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1101\/gad.12.21.3343","article-title":"Structure and specificity of nuclear receptor\u2013coactivator interactions","volume":"12","author":"Darimont","year":"1998","journal-title":"Genes Dev."},{"key":"B56","first-page":"614","article-title":"Selective thyromimetics: tissue-selective thyroid hormone analogs","volume":"4","author":"Scanlan","year":"2001","journal-title":"Curr Opin Drug Discov Dev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1021\/ja0440093","article-title":"Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists","volume":"127","author":"Nguyen","year":"2005","journal-title":"J Am Chem Soc."},{"key":"B58","doi-asserted-by":"publisher","first-page":"7354","DOI":"10.1073\/pnas.1131854100","article-title":"Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking","volume":"100","author":"Schapira","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1210\/mend.15.3.0608","article-title":"Hormone selectivity in thyroid hormone receptors","volume":"15","author":"Wagner","year":"2001","journal-title":"Mol Endocrinol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1038\/ncomms8048","article-title":"Transcriptional activation by the thyroid hormone receptor through ligand-dependent receptor recruitment and chromatin remodelling","volume":"6","author":"Gr\u00f8ntved","year":"2015","journal-title":"Nat Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6807-8-8","article-title":"Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms","volume":"8","author":"Bleicher","year":"2008","journal-title":"BMC Struct Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1074-5521(98)90168-5","article-title":"A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor","volume":"5","author":"Chiellini","year":"1998","journal-title":"Chem Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pharmthera.2011.04.003","article-title":"Thyromimetics: a journey from bench to bed-side","volume":"131","author":"Tancevski","year":"2011","journal-title":"Pharmacol Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11883-016-0564-7","article-title":"Thyroid hormone mimetics: the past, current status and future challenges","volume":"18","author":"Elbers","year":"2016","journal-title":"Curr Atherosc Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd2830","article-title":"Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes","volume":"8","author":"Baxter","year":"2009","journal-title":"Nat Rev Drug Discov."},{"key":"B66","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1073\/pnas.0705286104","article-title":"The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans","volume":"105","author":"Berkenstam","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10741-008-9122-x","article-title":"Sobetirome: a case history of bench-to-clinic drug discovery and development","volume":"15","author":"Scanlan","year":"2010","journal-title":"Heart Failure Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1210\/en.2016-1842","article-title":"A thyroid hormone\u2013based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy","volume":"158","author":"Hartley","year":"2017","journal-title":"Endocrinology."},{"key":"B69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S2213-8587(14)70006-3","article-title":"Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study","volume":"2","author":"Sjouke","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1021\/jm4019299","article-title":"Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a highly selective thyroid hormone receptor \u03b2 agonist in clinical trials for the treatment of dyslipidemia","volume":"57","author":"Kelly","year":"2014","journal-title":"J Med Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1073\/pnas.0702759104","article-title":"Targeting thyroid hormone receptor-\u03b2 agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index","volume":"104","author":"Erion","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e126329","DOI":"10.1172\/jci.insight.126329","article-title":"Myelin repair stimulated by CNS-selective thyroid hormone action","volume":"4","author":"Hartley","year":"2019","journal-title":"JCI Insight."},{"key":"B74","doi-asserted-by":"publisher","first-page":"112006","DOI":"10.1016\/j.ejmech.2019.112006","article-title":"Design, synthesis and biological evaluation of novel TR\u03b2 selective agonists sustained by ADME-toxicity analysis","volume":"188","author":"Runfola","year":"2020","journal-title":"Eur J Med Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e12808","DOI":"10.1111\/cpr.12808","article-title":"Potential role of two novel agonists of thyroid hormone receptor\u2013\u03b2 on liver regeneration","volume":"53","author":"Perra","year":"2020","journal-title":"Cell Prolif."},{"key":"B76","doi-asserted-by":"publisher","first-page":"26555","DOI":"10.1074\/jbc.M402847200","article-title":"Induction of larval tissue resorption in Xenopus laevis tadpoles by the thyroid hormone receptor agonist GC-1","volume":"279","author":"Furlow","year":"2004","journal-title":"J Biol Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1210\/endo.141.9.7681","article-title":"The thyroid hormone receptor-\u03b2-selective agonist GC-1 differentially affects plasma lipids and cardiac activity","volume":"141","author":"Trost","year":"2000","journal-title":"Endocrinology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.atherosclerosis.2014.09.035","article-title":"The thyroid receptor \u03b2 modulator GC-1 reduces atherosclerosis in ApoE deficient mice","volume":"237","author":"Kannisto","year":"2014","journal-title":"Atherosclerosis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200112584","article-title":"Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific","volume":"108","author":"Ribeiro","year":"2001","journal-title":"J Clin Invest."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1096\/fj.08-108464","article-title":"Thyroid hormone (T3) and TR\u03b2 agonist GC-1 inhibit\/reverse nonalcoholic fatty liver in rats","volume":"22","author":"Perra","year":"2008","journal-title":"FASEB J."},{"key":"B81","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1152\/ajpendo.00573.2012","article-title":"Thyroid hormone receptor-\u03b2 agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways","volume":"305","author":"Vatner","year":"2013","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0168-8278(09)60537-7","article-title":"Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype","volume":"49","author":"Perra","year":"2009","journal-title":"Hepatology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3727\/105221616X691631","article-title":"Thyroid hormone receptor \u03b2 agonist induces \u03b2-catenin-dependent hepatocyte proliferation in mice: Implications in hepatic regeneration","volume":"17","author":"Alvarado","year":"2016","journal-title":"Gene Exp."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/glia.22697","article-title":"A selective thyroid hormone \u03b2 receptor agonist enhances human and rodent oligodendrocyte differentiation","volume":"62","author":"Baxi","year":"2014","journal-title":"Glia."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1021\/acschemneuro.7b00239","article-title":"Targeting fatty-acid amide hydrolase with prodrugs for CNS-selective therapy","volume":"8","author":"Meinig","year":"2017","journal-title":"ACS Chem Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/thy.2018.0008","article-title":"Sobetirome and its amide prodrug Sob-AM2 exert thyromimetic actions in Mct8-deficient brain","volume":"28","author":"B\u00e1rez-L\u00f3pez","year":"2018","journal-title":"Thyroid."},{"key":"B87","doi-asserted-by":"publisher","first-page":"12528","DOI":"10.1523\/JNEUROSCI.1069-12.2012","article-title":"Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS","volume":"32","author":"Koenning","year":"2012","journal-title":"J Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature."},{"key":"B89","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1381612023395655","article-title":"Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications","volume":"8","author":"Bisogno","year":"2002","journal-title":"Curr Pharm Des."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.bmc.2017.03.047","article-title":"Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration","volume":"25","author":"Ferrara","year":"2017","journal-title":"Bioorg Med Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1016\/j.bmc.2016.09.038","article-title":"Sobetirome prodrug esters with enhanced blood\u2013brain barrier permeability","volume":"24","author":"Placzek","year":"2016","journal-title":"Bioorg Med Chem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/cmdc.201600408","article-title":"Increasing thyromimetic potency through halogen substitution","volume":"11","author":"Devereaux","year":"2016","journal-title":"ChemMedChem."},{"key":"B93","article-title":"Novel TR\u03b2-selective analog IS25 and its prodrug TG68 demonstrate significant liver regenerative capacity and lipid lowering effects","volume-title":"89th Annual Meeting of the American Thyroid Association 2019 October 30 - November 3","author":"Chiellini","year":"2019"},{"key":"B94","doi-asserted-by":"publisher","first-page":"105206","DOI":"10.1016\/j.dib.2020.105206","article-title":"Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics","volume":"29","author":"Runfola","year":"2020","journal-title":"Data Brief."},{"key":"B95","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jhep.2010.04.028","article-title":"TR\u03b2 is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells","volume":"53","author":"Kowalik","year":"2010","journal-title":"J Hepatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/105221617X695438","article-title":"The thyromimetic KB2115 (eprotirome) induces rat hepatocyte proliferation","volume":"17","author":"Szydlowska","year":"2017","journal-title":"Gene Exp J Liver Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2016.09.014","article-title":"Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease","volume":"167","author":"Finan","year":"2016","journal-title":"Cell."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/thy.2012.0458","article-title":"Thyroid hormone analogues: where do we stand in 2013?","volume":"23","author":"Meruvu","year":"2013","journal-title":"Thyroid."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00331\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T23:08:48Z","timestamp":1616540928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00331\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":98,"alternative-id":["10.3389\/fmed.2020.00331"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00331","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"article-number":"331"}}